3Q16 Earnings Release
São Paulo, November 9, 2016 – Alliar – Centro de Imagem Diagnósticos S.A. hereby announces its 3Q16 results.
- Net Revenue of R$253.7 million, up by 37.1% (+17.1% pro forma)
- Adjusted EBITDA of R$59.4 million, an increase of 45.7% (+27,3% pro forma) and Adjusted LTM EBITDA of R$200.6 million (share traded at EV/EBITDA of 11.1x )
- Adjusted pro forma EBITDA Margin of 23.4% (pro forma improvement of 188 bps)
- Recurring Net Income of R$14.1 million, versus a net loss of R$30.9 million in 3Q15
- LTM ROIC ex goodwill of 20.1%
- Installation of 2 new MRI machines (total of 114) and 9 new clinical analysis (CA) collection rooms (total of 183)
- Ongoing construction works in 7 new PSCs (3 mega and 4 collection points), led by the Ana Rosa and Morumbi mega PSCs in São Paulo (SP) (the first of which began operations on October 15) and the Bernardo Monteiro mega PSC in Belo Horizonte (MG).
- 4 target-companies undergoing due diligence
- 13 new medical partners, strengthening Alliar’s medical partnership model
- Conclusion of the integration of Delfin Imagem, acquired in March 2016
Click here to access the Earnings Release.
| Conference Call in English | Conference Call in Portuguese |
|---|---|
| November 10, 2016 12:30 p.m. (Local time) 9:30 a.m. (NY time) Phone: +1 (516) 300-1066 Phone: +55 (11) 3127-4971 Code: Alliar Webcast: click here Replay: available until 11/17 |
November 10, 2016 1:30 p.m. (Local time) 10:30 a.m. (NY time) Phone: +55 (11) 3127-4971 Code: Alliar Webcast: click here Replay: available until 17/11 |
IR Contact
Carlos Thiago de Souza Araujo
Investor Relations Officer
Email: ri@alliar.com